Welcome to the Urologic Cancer Epidemiology Lab at Stanford

We are a multidisciplinary research team studying the epidemiology of urologic cancers, especially kidney cancer.  The program was borne out of a need to better understand the underlying factors that predispose to urologic cancers, with a focus on kidney cancer, as these malignancies are potentially preventable once the underpinnings to pathogenesis are better understood. 

Why kidney cancer?

Renal cell carcinoma (RCC), or kidney cancer, creates a significant impact not only in the United States, but worldwide and the incidence rate is continuing to rise.  The understanding of etiologic factors causing RCC is poorly understood and incomplete, leading to lack of options from a preventative standpoint, especially in light of both an aging population and an increasing number of younger patients diagnosed with RCC.

What is epidemiology?

Epidemiology is the study of health and disease conditions and the identification of risk factors for diseases and in turn, potential targets for prevention.

Why urology?

Urologic cancers when detected early, are amongst the most curable of all cancers.  For those whom are detected at early stages, they can expect a long life expectancy.



If you are interested in supporting the work of the Urologic Cancer Epidemiology Lab, please contact Evelyn Klass-Rodewald, Medical Center Development, at evelyn.rodewald@stanford.edu